The Commercial Readiness Review
Science Led Founders Raise Their Series A. Then Find the Commercial Engine won't Scale.
The Commercial Readiness Review names the three commercial gaps costing you deals and the revenue they're quietly draining before your next round prices them in.
Commercial Leadership
Revenue Growth Driven
From Kickoff to Plan
Dimensions Diagnosed
The pattern we keep seeing
Post Series A. Strong Product. Fragile Commercial Engine. This is the Pattern That Stalls Series B.
Founder Adjacent Deals
Pricing Without Anchors
Fuzzy
ICP
Quiet Retention Leak
A Real Diagnosis Nuvyra
This is what the review actually finds.
Not a template. A live example: seven dimensions rated, three decisive gaps named, and the revenue each one is costing in pounds.
“The product is strong. The business around it is not yet built.”
Financial Impact Per Year
£170k
Left on the table, every year, from two fixable gaps.
- Underpriced deals - (£120k)
- Avoidable churn - (£50k)
Both gaps are correctable inside two to three quarters before the next raise prices them in for you.
Commercial Readiness Scorecard
Market Opportunity
Large, fast-growing R&D software market with budgeted demand and favourable timing.
STRONG
Ideal Customer
Five customers across three segments no sharp ICP to focus the motion.
WATCH
Reason to Buy
Sold on features and model quality, not buyer outcomes. Deals stall in evaluation.
WATCH
Proof & References
Thin referenceable evidence; little case material to de-risk new buyers.
WATCH
Pricing & Packaging
No list price. Deals range £25k - £75k, anchoring value below the sector norm.
GAP
Retention
Net retention in the low 80s%. One of six logos churned this year, no success motion.
GAP
Founder Independence
Both founders in every deal. Nothing closes without them.
GAP
The method
Seven Dimensions. Three Decide it.
The Thaver Commercial Readiness Index isn’t a generic SaaS scorecard. It weights what actually moves deals for science-led software, then isolates the three gaps doing the real damage the ones an investor will price.
Market Opportunity
Ideal
Customer
Reason to
Buy
Proof & References
Pricing & Packaging
Customer Retention
Founder Independence
What you walk away with
- The three decisive gaps named, with the reasoning behind each.
- The revenue they’re costing a grounded figure, in pounds.
- A prioritized 90-day plan sequenced, with clear owners.
The next step
Know Exactly Where You Stand, in Two Weeks.
Fixed scope
Two weeks. No retainer, no upsell.
2 weeks
From kickoff to diagnosis and plan.
90-day plan
Prioritized, with owners and timelines.
Built on experience supporting 10+ science and healthtech startups and helping drive more than $405M in revenue growth. Every review delivers a clear diagnosis, the commercial impact of your biggest gaps, and a prioritized 90-day action plan.